STAND. COM. REP. NO. 692-22

Honolulu, Hawaii

, 2022

RE: H.B. No. 1886

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-First State Legislature

Regular Session of 2022

State of Hawaii

Sir:

Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 1886, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"

begs leave to report as follows:

The purpose of this measure is to:

(1) Ban hemp products that contain cannabinoids created through isomerization, including Delta 8 tetrahydrocannabinol; and

(2) Add Delta 8 tetrahydrocannabinol to the list of schedule I controlled substances.

Your Committee received testimony in support of this measure from the Department of Health, Honolulu Police Department, and Mothers Against Drunk Driving Hawaii.

Your Committee finds that Delta 8 tetrahydrocannabinol (Delta 8 THC) is a psychoactive substance found in the Cannabis sativa plant. While Delta 8 THC is naturally produced in the cannabis plant, it is not found in significant amounts. As a result, concentrated amounts of Delta 8 THC are typically manufactured from hemp-derived cannabidiol.

Your Committee further finds that Delta 8 THC products have not been evaluated or approved by the United States Food and Drug Administration for safe use in any context and may be marketed in a manner that puts the public health at risk. This measure protects the public by prohibiting hemp products that contain Delta 8 THC and adding Delta 8 THC to the list of schedule I controlled substances.

As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1886, H.D. 1, and recommends that it pass Third Reading.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

____________________________

AARON LING JOHANSON, Chair